Introduction
Currently, miscarriage is considered to be a multietiological disorder with trombofilic violations and hormone deficiency as the leading factors. The problem of early pregnancy loss remains urgent because these factors are the most common complications without any downward tendency [1] [2] [3] [4] . According to the latest concepts, 80% of all pregnancy losses occur at the early stages. One of the first signs that threatens the pregnancy is subchorionic hematoma (SCH) [5, 6] . It is the most unfortunate sign of threatened abortion. It is established that the disruption of trophoblast invasion in the 1 st trimester of pregnancy leads to the advanced gestational complications: threatened abortion, preeclampsia, preterm delivery, pla cental abruption, which increase perinatal, in fant and ISSN 2413-6077. IJMMR 2016 Vol. 2 Issue 1 maternal mortality. The protective func tion of the immune system at the early stages of gestation such as the suppression of natural killer cells in the endometrium, mother's blocking fac tors production is provided by diffe rent mostly hormonal dependent mechanisms; their disorders lead to defects of implantation, SCH and can cause early pregnancy termination [3, 7] .
The endometrium and decidua contain a huge number of immune system cells, all of them are able to secrete cytokines. Main cyto kines that are secreted in the body inhibit the embryo development, proliferation and deve lop ment of normal trophoblast. They affect the embryo, both directly and indirectly, depending on the intensity of secretion and differentiation of target tissues [6] . Cytokine cascade can be triggered by infectious agent and by endogenous factors (hypoxia, hormones, etc.) as well. Per sis tent viral bacterial infection, neuroen docrine disorders, chromosomal ab nor malities, the toxic effects, stress and envi ronment are also etio logical factors of early abortion [8, 9] . Despite the achievements in treatment of mis carriage, the frequency of preterm termination of the wan ted pregnancies is still high and the number of perinatal losses is significant. Therefore, pathogenetically based therapy, safe for the foetus, is very important in management of pre gnancy interruption in the first trimester. A proper drugs administration provides optimal concentration of active ingredients and fast action.
The aim is to improve effectiveness of the early threatened abortion treatment in cases of subchorionic hematoma by combination of sublingual natural micronized progesterone and tranexamic acid.
Materials and Methods
The examination of 50 pregnant women was conducted at the Department of Gynaecology of Ternopil Regional Perinatal Centre "Mother and Child". They received treatment for threatened abortion in gestational age from 8 to 12 weeks. All women were diagnosed with SCH by means of ultrasound.
To exclude infection as an etiological factor of abortion, bacteriological research of TORCH and sexually transmitted infections were conducted. All patients had negative results of the tests for these infections.
System of haemostasis was evaluated by determination of platelet and aggregation time, prothrombin index (PI), thrombin clotting time, activated partial thromboplastin time (APTT), fibrinogen concentration.
Basic hormonal markers of abortion were also studied: the concentration of free estriol and progesterone by radioimmunoassay method, sets made by company "SORIN" (France), and radioisotope sets Amerlayt made by international company Amersham. β-subunit of human chorionic gonadotropin (β-hCG) concen tration was determined by immune fluorescence analysis with time resolution (test system Delfiya, Wallac, Perkinelmer) (according to the manufacture standard protocol of test systems).
To determine efficacy of the proposed complex of therapeutic measures, all the pregnant were tested with transvaginal ultrasound on the 14 th day of the treatment. The pregnant of the 1 st group (n=25; the comparison group) received supportive therapy -sedation, spasmolytic, haemostatic drug. The pregnant of 2 nd group (n=25), together with supportive therapy, received tranexamic acid 2 ml (500 mg) dissolved in 200 ml normal saline solution intravenously till the arrest of bleeding and natural micronized progesterone 100 mg three times a day sublingually. The control group consisted of 20 healthy pregnant women without any symptoms of threatened abor tion.
Results and Discussion
The evaluation of plasma-coagulation and vascular-platelet hemostasis showed minimal signs of hypercoagulation, hyperfibrinogenemia and platelet hyperactivity if compared with the women with physiological pregnancy. This suggests a thrombophilia as an etiopathogenetic factor of early abortion with SCH in the examined women.
The evaluation of hormonal homeostasis showed, that at the early gestational age a significant β-hCG level decrease and approximate decrease in progesterone and free estriol production were the diagnostic markers of threatened abortion with SCH The results of ultrasound examination showed, that SCH was located in the area of the lower chorion in 32 (64%) of the pregnant women, in the central part -in 18 (36%) pati ents. Also sonographic examination showed other markers of abortion. So, local myometrial hyper tonus was diagnosed in 43 (86%) pregnant women, deformation of fertilized egg -in 32 (64%), hypoplasia of chorion -in 12 (24%), low location of fertilized ovum -8 (16%), retarded growth of CRL -in 2 (4%).
The research proved that combined administration of sublingual micronized progesterone Obstetrics and GynecOlOGy issn 2413-6077. iJMMr 2016 Vol. 2 issue 1 and tranexamic acid for the treatment of threatened abortion with SCH has more sig nificant positive effect for pregnancy main tenance due to clinical, biochemical, hormonal and ultrasound results if compared with the group which underwent supportive therapy.
After the symptomatic treatment a spon taneous abortion happened in 6 (24%) women, missed abortion in -6 (24%), gestational pro cess complicated by hyperemesis gravidarum which required additional therapy -in 4 (16%). Among 25 women of the 2 nd group spontaneous abortion occurred in 3 (12%) patients, missed abortion -in 1 (4%) woman.
The results of our research have shown that in women of the 2 nd group the level of platelets increased and did not significantly differ from the control group findings. In patients of the 1 st group it was significantly lower than in women of the 2 nd and control groups. The similar chan ges were evidenced in the evaluation of PI.
In 2 weeks of the proposed therapy, the level of βhCG increased in both groups of women, but in the 2nd group it did not sig nificantly differ from the control group. After the treatment the level of free estriol and pro gesterone increased and did not significantly differ from the control group with the similar results.
Symptomatic and complex treatment sig nificantly reduced the sonographic signs of abortion, but in the 2 nd group these changes pronounced more positive trend than in the 1 st group. So, in 18 (72%) pregnant women of the 2 nd group and in 4 (16%) -of the I group (p<0,05) there was a complete resumption of SCH, hematoma decreased in size in 3 (12%) women of each group.
Thus, the prescription of micronized proges terone sublingually provides an inhibitory effect on the contractile activity of myofibrils, prevents the further chorine detachment that leads to pregnancy maintenance and prevents repro ductive losses.
Our research demonstrates the necessity of the inclusion of micronized progesterone in 100 mg 3 times daily sublingually and tranexamic acid 500 mg intravenously to the treatment protocol of early threatened abortion with SCH. Also this treatment is more effective if compared with the traditional supportive therapy (seda tion, spasmolytic, haemostatic drug).
Conclusions

1.
Complex application of natural micronized progesterone 100 mg three times a day sub lingually and 500 mg of Tranexamic acid dissolved in 200 ml normal saline solution improves the dynamics of the main hormonal, haemostatic and ultrasound markers of abor tion and significantly reduces reproductive losses.
2. Tranexamic acid treatment proved a rapid and effective action on hematoma and absence of embryotoxical and сoagulopathyc influence. Tranexamic acid does not cause any significant disorders of hemostatic system. This is very important at the early gestation because of intravascular coagulation, physiological hyper coagulable condition during pregnancy that can cause microthrombosis and disrupt pla centation. On the other hand, it is dangerous for the mother's health because of the in creased risk of thrombosis.
